Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care
Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care(600 views) Cuocolo A, Acampa W, Varrone A, Salvatore M
Keywords: Annual Congress 2005, Highlights, Istanbul, Nuclear Medicine, 1 (1 Phenylethyl) 1h Imidazole 5 Carboxylic Acid 2 Fluoroethyl Ester F 18, 10 Tetraazacyclododecane 1, 10 Tetraacetic Acid, 11beta Hydroxylase Inhibitor, Diagnostic Agent, Dpc 11870, Enzyme Inhibitor, Fluorodeoxyglucose F 18, Fluorouracil, Folinic Acid, Iodomethyltyrosine I 123, Ketanserin, Leukotriene B4 Receptor Antagonist, Lipocortin 5 Tc 99m, Methoxy Isobutyl Isonitrile Technetium Tc 99m, Metomidate C 11, Monoclonal Antibody, O (2 Fluoroethyl)tyrosine F 18, Octreotate[3 Tyrosine 1, Oxaliplatin, Pentetate Technetium Tc 99m, Raclopride C 11, Radioisotope, Radiopharmaceutical Agent, Serotonin 2a Antagonist, Tetrofosmin Tc 99m, Tirapazamine, Tracer, Unclassified Drug, Unindexed Drug, Yp 533, Zirconium Derivative, Biomedicine, Cardiology, Computer Assisted Emission Tomography, Conference Paper, Diagnostic Accuracy, Diagnostic Imaging, Human, Infection, Inflammation, Information Processing, Lymphoscintigraphy, Medical Education, Medical Instrumentation, Nonhuman, Oncology, Patient Care, Positron Emission Tomography, Prognosis, Radiochemistry, Reproducibility, Risk Assessment, Single Photon Emission Computer Tomography, Treatment Planning, Biomedical Research, Clinical Trials, Clinical Trials As Topic, Delivery Of Health Care, Radiotherapy, O (2 Fluoroethyl) Tyrosine F 18, Octreotate [3 Tyrosine 1,
Affiliations: *** IBB - CNR ***
Department of Biomorphological and Functional Sciences, University of Naples Federico II, Via S. Pansini 5, 80131 Napoli, Italy
Institute of Biostructures and Bioimages of the National Council of Research, Naples, Italy
References: Beck, R., Carlsen, J.M., Lebschi, J.A., Huisman, M.C., Reder, S., Röper, B., Prognostic value of 18F-FAZA uptake for the efficiency of radiotherapy and hypoxia-directed chemotherapy in a murine tumor hypoxia model (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S3
Van Dongen, G.A.M.S., Borjesson, P.K.E., Roos, J.C., Jauw, Y.W.S., Boellaard, R., Comans, E.F.I., Immuno-PET using zirconium-89-labeled chimeric MAb U36 for detection of lymph node metastases in head and neck cancer patients (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S79
Acampa, W., Spinelli, L., Sorrentino, A.R., Capacchione, D., Paone, G., Petretta, M., Comparison of prognostic value of negative dobutamine stress echocardiography vs single photon emission computed tomography after acute myocardial infarction (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S55
Soler Peter, M., Santana, C., Ribera, A., Faber, T., Shaw, L., Garcia, E., Prognostic value of left ventricular functional parameters by gated-FDG PET in ischaemic cardiomyopathy patients (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S178
Seneca, N., Finnema, S., Ichise, M., Gulyas, B., Wikstrom, H., Innis, R., A comparison of amphetamine induced changes in agonist and antagonist radioligand binding potential on the dopamine D2 receptor in primate brain (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S82
Finnema, S.J., Seneca, N., Farde, L., Gulyás, B., Bang-Andersen, B., Wikström, H.V., Scatchard analysis of the D2 receptor agonist [11C]MNPA in the monkey brain using PET (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S82
Ferrari, M., Cremonesi, M., Rossi, A., Militano, D., Chinol, M., Trifirò, G., Risks and optimization of radiation protection in radionuclide therapies with 90Y-conjugates (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S120
Slosman, D.O., Quinodoz, M., Willi, J.P., Adequacy of PET imaging for monitoring treatment using SUV in clinical setting: Proposal of standard indicators (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S36
Chan, S.C., Yen, T.C., Chang, T.C., Lin, C.Y., Standardized uptake value of 2-[18F] fluoro-2-deoxy-D-glucose in predicting treatment outcome of primary nasopharyngeal carcinoma: A preliminary report (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S162
Simonnet, J.A., Itti, E., Haioun, C., Rahmouni, A., Mahloul, M., Lepage, E., Predictive value of 18F-fluorodesoxyglucose positron emission tomography (FDG-PET) in aggressive non Hodgkin's lymphoma with partial or unconfirmed response according to Cheson criteria (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S161
Zhao, J., Gun, Y.H., Lu, S., Zuo, C.T., Lin, X.T., Detection of recurrent non-small cell lung cancer with integrated 18F-FDG PET/CT (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S105
Baum, R.P., Niesen, A., Leonhardi, J., Wortmann, R., Müller, D., Rösch, F., Receptor PET/CT imaging of neuroendocrine tumors using the Ga-68 labelled, high affinity somatostatin analogue DOTA-1-Na13-octreotide (DOTA-NOC): Clinical results in 327 patients (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S54
Gutte, G., Jacobsson, D., Olofsson, F., Ohlsson, M., Jakobsen, A.L., Valind, S., Automated interpretation of PET/CT images in patients with lung cancer (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S143
Bural, G.G., Shrikanthan, S., Dhurairaj, T., Urhan, M., Srinivas, S., Houseni, M., Lymph node necrosis in FDG-PET images in lymphoma and its clinical significance (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S145
Picchio, M., Sironi, S., Rabaiotti, E., Moreni, R., Surace, M., Mangili, G., Influence of PET/CT on the clinical management of patients with suspected ovarian cancer recurrence (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S72
Schütz, M., Wadsak, W., Mitterhauser, M., Rendl, G., Paul, M., Dudczak, R., Adrenocortical PET imaging with the novel tracer [18F]FETO: Preliminary results in healthy volunteers (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S29
Strauss, L.G., Koczan, D., Hoffend, J., Haberkorn, U., Pan, L., Dimitrakopoulou-Strauss, A., Evaluation of early effects of chemotherapy using a human colorectal cancer cell line (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S36
Laverman, P., Frielink, C., Morsche, R.H., Oyen, W.J.G., Boerman, O.C., Drenth, J.P.H., Early detection of cholangiocarcinoma with [18F]FDG in a rat model (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S96
Spanu, A., Pirina, P., Schillaci, O., Solinas, M.E., Chessa, F., Marongiu, P., The usefulness of 99mTc-tetrofosmin SPECT in the detection of primary lung cancer (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S140
Hubalewska-Dydejczyk, A., Fross, K., Mikolajczak, R., Pach, D., Sowa-Staszczak, A., Maecke, H.R., 99mTc-EDDA/HYNIC-tate - An optimal radiotracer for detecting and staging of carcinoid tumors? (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S108
Solá, M., Fuertes, S., Fraile, M., Rull, M., Julián, J.F., Gubern, J.M., Sentinel lymph node biopsy and immunohistochemical examination of bone marrow for the detection of isolated tumor cells in early stage breast cancer (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S137
Gomes, C.M.F., Cleton-Jansen, A.M., Welling, M.M., Van Paassen, H., Hogendoorn, P.C.V., Abrunhosa, A.J., Monitoring multidrug resistance (MDR) in osteosarcoma cell lines with 99mTc-sestamibi (MIBI) and 99mTc-tetrofosmin (Tfs) (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S99
Kartachova, M.S., Haas, R.L.M., Verheij, M., Valdés Olmos, R.A., Correlation between in vivo imaging of apoptosis by 99mTc- annexin V scintigraphy and tumor response in patients with malignant lymphoma (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S99
Kroon, B.K., Valdés Olmos, R.A., Van Tinteren, H., Nieweg, O.E., Horenblas, S., Reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S48
Maccauro, M., Solima, E., Villano, C., Aliberti, G., Bavusi, S., Castellani, M., Sentinel lymph node detection following the hysteroscopic peritumoral injection of 99m Tc labelled albumin nanocolloid in endometrial cancer (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S49
Armas, F., Hernández, M., Perera, C., Travieso, J., Isla, C., Rodríguez, J., Comparison between subareolar and peritumoral injection techniques with 99mTc-nanocolloid for sentinel node detection in breast cancer (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S118
Moretti, A., Ridolfi, R., Riccobon, A., Galassi, R., Giorgetti, G., Stefanelli, M., Evaluation of in vivo migration of mature and immature radiolabelled dendritic cells and the different route of administration in cancer patients (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S136
Picard, C., Abouhammad, P., Gerber, B., Belge, B., Vanoverschelde, J.L., Roelants, V., Effect of temporal sampling on the evaluation of regional left ventricular function by ECG-gated perfusion SPECT in patients with severe ischemic cardiomyopathy in comparison with MRI (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S178
Bertagna, F., Bosio, G., Terzi, A., Paghera, B., Bettinsoli, G., Cuccia, C., The contribution of gated-SPECT to predict left ventricular remodelling after acute myocardial infarction (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S45
Ferro, A., Spinelli, L., Acampa, W., Pellegrino, T., Capacchione, D., De Corato, G., Direct comparison of interpretative reproducibility of stress myocardial perfusion imaging and stress echocardiography for the detection of inducible ischemia (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S38
Ferro, A., Acampa, W., De Rimini, M.L., Cittanti, C., Marranzano, F., Spadafora, M., A prospective, multi-center trial to identify the prevalence of inducible ischemia in patients presenting with diabetes and suspected or known coronary artery disease: Preliminary results (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S38
Yapar, A.F., Aydin, M., Reyhan, M., Sukan, A., Prognostic value of normal stress SPECT myocardial perfusion scintigraphy in diabetic patients with no known coronary artery disease (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S175
Magagnoli, G., Pizzi, C., Morelli, R., Gavaruzzi, G., Guidalotti, P., Levorato, M., Prognosis of myocardial reversible perfusion in patients with angina and normal coronary angiograms (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S55
Valle, G., Stanislao, M., Gimelli, A., Perrone, E., Martino, G., De Rito, V., Gated single photon emission computed tomography (g-SPECT) in predicting cardiac resynchronization therapy (CRT) effectiveness (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S165
Pirich, C., Graf, S., Nikfardjam, M., Khorsand, A., Ofluoglu, S., Nekolla, S.G., Improvement in coronary vasoreactivity by folic acid is not related to homocysteine levels in subjects with coronary artery disease as assessed by N-13 ammonia PET (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S90
Flotats, A., Simó, M., Campreciós, M., García, J., Soler, M., Rodriguez, A., Myocardial blood flow and glucose metabolism during the first six months of human heart transplantation (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S174
Kampen, W.U., Zuhayra, M., Gierthmühlen, M., Sommer, P., Faendrich, F., Hedderich, J., Tc-99m labeled oligonucleotides against IL-2 mRNA for imaging of acute heart transplant rejection in a rat model (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S106
Bural, G.G., Chamroonrat, W., Torigian, D.A., El-Haddad, G., Alavi, A., Quantitative assesment of atherosclerotic burden, using SUVs and wall volumes of major arteries by combined FDG-PET and CY imaging (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S90
Sarda-Mantel, L., Coutard, M., Rouzet, F., Vrigneaud, J.M., Vanderheyden, J.L., Merlet, P., 99mTc-annexin V imaging of thrombus activity in experimental rat aortic aneurysms (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S106
Tamagnan, G.D., Haile, C.N., Brenner, E., Koren, A.O., Bois, F., Amici, L., [I-123] INER (YP-533), a high affinity SPECT imaging agent for the norepinephrine transporter (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S81
Catafau, A.M., Danus, M., Bullich, S., Abanades, S., Barbanoj, M., Penengo, M.M., Ketanserin dose dependent displacement of the 5HT2A receptor SPECT ligand 123I-R91150 (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S81
Poepperl, G., Mehrkens, J.H., Koch, W., Kreth, F.W., Gildehaus, F.J., Tonn, J.C., Correlation of FET uptake kinetics and tumor grading in patients with suspected recurrent gliomas (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S40
Henze, M., Özdemir-Sahin, N., Hipp, P., Mier, W., Eisenhut, M., Debus, J., Comparison of the diagnostic accuracy of 18F-FDG PET, 123I-IMT- and 99mTc-MIBI SPECT in the evaluation of tumour progression in irradiated low grade astrocytomas with ROC-analysis (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S41
Buchmann, I., Bense, S., Schlindwein, P., Buchholz, H., Dieterich, M., Bartenstein, P., FDG-PET: Neuronal correlates of visual self-motion perception (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S187
Varrone, A., Pagani, M., Salmaso, D., Salvatore, E., Sansone, V., Nobili, F., Anterior cingulate hypoperfusion can differentiate progressive supranuclear palsy from Parkinson's disease: Voxel-based analysis and CBA-based PCA analysis of 99mTc-ECD SPECT data (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S64
Giovanella, L.C., Ceriani, L., Keller, F., Sacchi, A., Low-risk differentiated thyroid carcinoma restaging: Comparison of onT4-TG assay, neck ultrasound with TG assay on needle fluids and rhTSH-(TG assay+131J-WBS) (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S112
Voelker, T., Sinha, K., Steffen, I., Misch, D., Furth, C., Hautzel, H., FDG-PET imaging for staging and follow-up of malignant pediatric sarcomas: Preliminary results of a prospective multicenter study (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S75
Zucchetta, P., Biffanti, R., Ruscazio, M., Montisci, R., Marzola, M., Cecchin, D., Tc-MIBI adenosine G-SPECT and non-invasive coronary flow velocity reserve evaluation during follow-up of patients after cardio-pulmonary by-pass operated for congenital heart disease (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S86
Uchiyama, M., Nishimoto, H., Nozawa, K., Oguma, E., Kouno, T., Cerebral blood flow SPET and response to acetazolamide challenge in premature craniosynostosis before and after surgery (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S75
De Palma, D.D., Manzoni, G.A., Surgical risk for primary non-refluxing megaureter: Are ultrasonographic and scintigraphic measurements prognostic values? (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S84
Pifarre, P., Irastorza, I., Hill, S., Roca, I., Gordon, I., V/Q scan in assessment of long-term parenteral nutrition (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S85
Prandini, N., La Corte, R., Lo Monaco, A., Fabbri, S., Costanzo, A., Cittanti, C., Alveolar clearance of 99mc-DTPA aerosol in the evaluation of lung involvement in 190 patients with systemic sclerosis (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S25
Sandler, M.P., Patton, J.A., Ben-Haim, S., Coleman, R.E., Goldsmith, S.J., Vidan, E., Wide beam reconstruction method for half SPECT scan time: A multi-center clinical evaluation (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S50
Bar-Sever, Z., Steinmetz, A., Shwartz, S.C., Enhancement of I-123 MIBG scans in children using the wide beam reconstruction method: Preliminary evaluation (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S129
Boussion, N., Hatt, M., Lamare, F., Turzo, A., Bizais, Y., Cheze Le Rest, C., A multiresolution approach in partial volume correction for emission tomography imaging (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S51
Mier, W., Graham, K.A.N., Krämer, S., Hoffend, J., Haberkorn, U., Eisenhut, M., Characterization of peptide-conjugated DOTA-oligomers (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S150
Wild, D., Zhang, H., Waser, B., Schuhmacher, J., Haberkorn, U., Reubi, J.C., Preclinical evaluation of DOTA-PEG4-bombesin (7-14), a very promising ligand for gastrin releasing peptide receptor targeting (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S77
Van Eerd, J.J.E.M., Broekema, M., Harris, T., Edwards, S.D., Oyen, W.J.G., Corstens, F.H.M., Improved 99mTc-labeled LTB4 antagonist for imaging of infection and inflammation (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S35
Furumoto, S., Okamura, N., Ishikawa, Y., Tashiro, M., Kato, M., Funaki, Y., [11C]BF227: A new 11C-labeled 2-ethenylbenzoxazole derivative for amyloid-β plaques imaging (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S268
Courbon, F., Meynard, K., Cassol, E., MAGIC Polymer gel for internal targeted radiotherapy: Preliminary dosimetry study with unsealed source of yttrium 90 (90-Y) (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S110
Pettinato, C., Marengo, M., Ciuffrida, A., Civollani, S., Pancaldi, D., Laudicina, L., Self-absorbtion and 18F-FDG emission spectrum: Effects on the shielding determination in a PET diagnostic room (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S68
Petrich, T., Korkmaz, Z., Knapp, W.H., Quintanilla-Martinez, L., Pötter, E., Experimental therapy by the alpha-particle emitter [At-211]-astatine of NIS expressing tumors in a mouse model (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S274
Dadparvar, S., Berkowitz, A., Shrikanthan, S., Schuster, S., Alavi, A., Comparison of In-111 labeled anti-CD20 antibody and FDG-PET imaging in low grade lymphomas prior to therapy: Can we predict the response to Y-90 Zevalin therapy? (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S25
Alonso, O., Chae, I., Chung, J., Gutierrez, C., Kropp, J., Onsel, C., Intravascular radiation therapy with liquid-filled 188Re balloon catheter: Results of an International Atomic Energy Agency (IAEA) multicentre study (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S58
Nagy, Z., Bokori, G., Molnar, F., Major, L., Preda, I., Szilvasi, I., Intracoronary radionuclide therapy with liquid Re-188 to prevent restenosis. Biological factors (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S58
Durak, H., Nuclear magic (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S1-S3
Van Dongen, G. A. M. S., Borjesson, P. K. E., Roos, J. C., Jauw, Y. W. S., Boellaard, R., Comans, E. F. I., Immuno-PET using zirconium-89-labeled chimeric MAb U36 for detection of lymph node metastases in head and neck cancer patients (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S79
Finnema, S. J., Seneca, N., Farde, L., Guly s, B., Bang-Andersen, B., Wikstr m, H. V., Scatchard analysis of the D2 receptor agonist [11C] MNPA in the monkey brain using PET (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S82
Slosman, D. O., Quinodoz, M., Willi, J. P., Adequacy of PET imaging for monitoring treatment using SUV in clinical setting: Proposal of standard indicators (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S36
Chan, S. C., Yen, T. C., Chang, T. C., Lin, C. Y., Standardized uptake value of 2- [18F] fluoro-2-deoxy-D-glucose in predicting treatment outcome of primary nasopharyngeal carcinoma: A preliminary report (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S162
Simonnet, J. A., Itti, E., Haioun, C., Rahmouni, A., Mahloul, M., Lepage, E., Predictive value of 18F-fluorodesoxyglucose positron emission tomography (FDG-PET) in aggressive non Hodgkin's lymphoma with partial or unconfirmed response according to Cheson criteria (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S161
Zhao, J., Gun, Y. H., Lu, S., Zuo, C. T., Lin, X. T., Detection of recurrent non-small cell lung cancer with integrated 18F-FDG PET/CT (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S105
Baum, R. P., Niesen, A., Leonhardi, J., Wortmann, R., M ller, D., R sch, F., Receptor PET/CT imaging of neuroendocrine tumors using the Ga-68 labelled, high affinity somatostatin analogue DOTA-1-Na13-octreotide (DOTA-NOC): Clinical results in 327 patients (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S54
Bural, G. G., Shrikanthan, S., Dhurairaj, T., Urhan, M., Srinivas, S., Houseni, M., Lymph node necrosis in FDG-PET images in lymphoma and its clinical significance (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S145
Sch tz, M., Wadsak, W., Mitterhauser, M., Rendl, G., Paul, M., Dudczak, R., Adrenocortical PET imaging with the novel tracer [18F] FETO: Preliminary results in healthy volunteers (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S29
Strauss, L. G., Koczan, D., Hoffend, J., Haberkorn, U., Pan, L., Dimitrakopoulou-Strauss, A., Evaluation of early effects of chemotherapy using a human colorectal cancer cell line (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S36
Sol, M., Fuertes, S., Fraile, M., Rull, M., Juli n, J. F., Gubern, J. M., Sentinel lymph node biopsy and immunohistochemical examination of bone marrow for the detection of isolated tumor cells in early stage breast cancer (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S137
Gomes, C. M. F., Cleton-Jansen, A. M., Welling, M. M., Van Paassen, H., Hogendoorn, P. C. V., Abrunhosa, A. J., Monitoring multidrug resistance (MDR) in osteosarcoma cell lines with 99mTc-sestamibi (MIBI) and 99mTc-tetrofosmin (Tfs) (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S99
Kartachova, M. S., Haas, R. L. M., Verheij, M., Vald s Olmos, R. A., Correlation between in vivo imaging of apoptosis by 99mTc- annexin V scintigraphy and tumor response in patients with malignant lymphoma (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S99
Kroon, B. K., Vald s Olmos, R. A., Van Tinteren, H., Nieweg, O. E., Horenblas, S., Reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S48
Armas, F., Hern ndez, M., Perera, C., Travieso, J., Isla, C., Rodr guez, J., Comparison between subareolar and peritumoral injection techniques with 99mTc-nanocolloid for sentinel node detection in breast cancer (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S118
Yapar, A. F., Aydin, M., Reyhan, M., Sukan, A., Prognostic value of normal stress SPECT myocardial perfusion scintigraphy in diabetic patients with no known coronary artery disease (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S175
Flotats, A., Sim, M., Campreci s, M., Garc a, J., Soler, M., Rodriguez, A., Myocardial blood flow and glucose metabolism during the first six months of human heart transplantation (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S174
Kampen, W. U., Zuhayra, M., Gierthm hlen, M., Sommer, P., Faendrich, F., Hedderich, J., Tc-99m labeled oligonucleotides against IL-2 mRNA for imaging of acute heart transplant rejection in a rat model (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S106
Bural, G. G., Chamroonrat, W., Torigian, D. A., El-Haddad, G., Alavi, A., Quantitative assesment of atherosclerotic burden, using SUVs and wall volumes of major arteries by combined FDG-PET and CY imaging (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S90
Tamagnan, G. D., Haile, C. N., Brenner, E., Koren, A. O., Bois, F., Amici, L., [I-123] INER (YP-533), a high affinity SPECT imaging agent for the norepinephrine transporter (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S81
Catafau, A. M., Danus, M., Bullich, S., Abanades, S., Barbanoj, M., Penengo, M. M., Ketanserin dose dependent displacement of the 5HT2A receptor SPECT ligand 123I-R91150 (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S81
Henze, M., zdemir-Sahin, N., Hipp, P., Mier, W., Eisenhut, M., Debus, J., Comparison of the diagnostic accuracy of 18F-FDG PET, 123I-IMT- and 99mTc-MIBI SPECT in the evaluation of tumour progression in irradiated low grade astrocytomas with ROC-analysis (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S41
Giovanella, L. C., Ceriani, L., Keller, F., Sacchi, A., Low-risk differentiated thyroid carcinoma restaging: Comparison of onT4-TG assay, neck ultrasound with TG assay on needle fluids and rhTSH- (TG assay+131J-WBS) (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S112
De Palma, D. D., Manzoni, G. A., Surgical risk for primary non-refluxing megaureter: Are ultrasonographic and scintigraphic measurements prognostic values? (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S84
Sandler, M. P., Patton, J. A., Ben-Haim, S., Coleman, R. E., Goldsmith, S. J., Vidan, E., Wide beam reconstruction method for half SPECT scan time: A multi-center clinical evaluation (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S50
Van Eerd, J. J. E. M., Broekema, M., Harris, T., Edwards, S. D., Oyen, W. J. G., Corstens, F. H. M., Improved 99mTc-labeled LTB4 antagonist for imaging of infection and inflammation (2005) Eur J Nucl Med Mol Imaging, 32 (1 SUPPL.), pp. S35
Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care
Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care
Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care
Aloj L, Aurilio M, Rinaldi V, D'Ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, Von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, De Jong M * The EEE project(449 views) Proc Int Cosm Ray Conf Icrc Universidad Nacional Autonoma De Mexico, 2007; 5(HEPART2): 977-980. Impact Factor:0 ViewExport to BibTeXExport to EndNote